Authors
Loading...
Randomized trial explores alternative markers for glycaemic control in type 2 diabetes and chronic kidney disease, suggesting better monitoring methods.
Iftikhar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: